Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success

October 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Oct. 1 /- The pharmaceutical and biotechnology sectors have long turned to the market research function to help organizations navigate the competitive landscape. As the marketplace has evolved, leading organizations have learned that the market research function needs...

New National Program to Study and Establish Pediatric Dosing

October 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

KANSAS CITY, Mo., Oct. 1 /- A new national initiative, the Pediatric Trials Network (PTN), was created this week with a $95 million grant supported by the National Institutes of Health (NIH).  The PTN will be led through collaboration between the Eunice Kennedy Shriver National...

New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease

October 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

FORT LEE, N.J., Oct. 1 /- Neurologix, Inc. (OTC Bulletin Board: NRGX ), today announced that new details of the company's landmark, randomized, double-blind Phase 2 clinical trial of NLX-P101, its investigational gene therapy for advanced Parkinson's disease (PD), were presented during a...

Advertisement

CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month

October 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Oct. 1 /- October is American Pharmacists Month and CVS Caremark is recognizing its 26,000 pharmacists who provide outstanding care to their patients every day in its retail pharmacies, mail service pharmacies and specialty pharmacies across the country. (Logo:...

DMC Sinai-Grace Selects Loopback Communications' Readmission Reduction™ Services

October 1, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

DALLAS, Oct. 1 /- DMC Sinai-Grace Hospital has selected Dallas-based Loopback Communications' technology-leading Readmission Reduction™ solution to support its efforts to reduce readmissions of discharged patients. "DMC Sinai-Grace is committed to continuous quality improvement and...

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H

October 1, 2010 9:32 am | by AACR | News | Comments

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H., assistant secretary for health, U.S. Department of Health and Human Services

Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., Oct. 1 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana® (cabazitaxel) Injection, was published in the...

VirtualScopics Revenues Hit Another Quarterly Record

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Oct. 1 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a provider of quantitative imaging for clinical trials, today announced revenues for the third quarter ended September 30, 2010 exceeded $3.5 million, representing a greater than 25% increase over the comparable period in...

Advertisement

Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Oct. 1 /- Elekta recently launched ABAS ( Atlas-based Autosegmentation ) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase contouring accuracy. ABAS—considered the industry gold standard for autosegmentation...

Cancer Health Disparities: Challenges and Opportunities

October 1, 2010 7:34 am | by AACR | News | Comments

Disparities 2010: “Cancer Health Disparities: Challenges and Opportunities” includes perspectives from numerous Congressional officials, Federal agency leaders and a clinician on possible policy prescriptions that are necessary to help reduce cancer health disparities.

Mylan Launches Generic Version of Wellbutrin XL® Tablets

October 1, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 1 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bupropion Hydrochloride Extended-release Tablets USP, (XL), 150 mg and 300 mg (Once-Daily), the generic version of GlaxoSmithKline's antidepressant Wellbutrin XL...

Disparities 2010: Interview with Eddie Reed, M.D.

September 30, 2010 3:34 pm | by AACR | News | Comments

Disparities 2010: Eddie Reed, M.D., clinical director, University of South Alabama Mitchell Cancer Institute Dr. Reed talks about the challenges of health disparities he experiences in his work, the recruitment and retention of members of minority populations in cancer clinical trials and...

FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine

September 30, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Sept. 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat...

Advertisement

HHS Awards $473 Million in Patient-Centered Outcomes Research Funding

September 30, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Sept. 30 /PRNewswire-USNewswire/ -- HHS' Agency for Healthcare Research and Quality today announced the award of $473 million in grants and contracts to support projects that will help people make health care decisions based on the best evidence of effectiveness. The...

New Multi-Center Study Finds Clinical Practice Change with Masimo SET Pulse Oximetry Reduces Severe Eye Damage More Than 50% in Premature Newborns

September 30, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 30 /- Masimo (Nasdaq: MASI ) announced today that a new multi-center study published in the International Peer-Reviewed Academic Journal, Acta Paediatrica, shows that a change in clinical practice with the use of Masimo SET pulse oximetry technology led to a...

Disparities 2010: Interview with Timothy R. Rebbeck, Ph.D.

September 30, 2010 1:32 pm | by AACR | News | Comments

Disparities 2010: Interview with Timothy R. Rebbeck, Ph.D., associate director of population science at the Abramson Cancer Center at University of Pennsylvania

Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

VIENNA, Sept. 30 /- Intercell AG (VSE: ICLL) today announced that effective October 1, 2010, Staph Leavenworth Bakali will join its Management Board as Chief Business Officer with key responsibilities for the commercial aspects of the Company, directly leading Marketing and Sales,...

BioSpace Showcases Southern California's Growing Life Science Region

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

DENVER, Sept. 30 /- BioSpace has promoted biotechnology, pharmaceutical and medical device industries in San Diego and Southern California for more than a decade. (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO) (Logo:...

Largest Study of Melanoma in US Hispanics Reveals California Population in Need of Targeted Prevention Efforts

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif., Sept. 30 /- Scientists at the Cancer Prevention Institute of California (CPIC) , Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in...

Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomat...

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Sept. 30 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, according to surveyed European oncologists, Johnson & Johnson's abiraterone will capture greater patient share than...

Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, Sept. 30 /- People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms. Data presented this week at the 2nd...

Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 30 /- A global pharmaceutical company has initiated a prospective trial to evaluate the impact of insulin guidelines developed by the Indian National Consensus group in collaboration with Max Neeman, a leading India-based Contract Research Organization....

New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement

September 30, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, Sept. 30 /- Healthpoint today announced that the results of a new study conducted by Catherine T. Milne APRN, MSN, CWOCN, BC-ANP, will be presented on Thursday, September 30, 2010 at 7:15pm (Eastern) at the Healthpoint booth (#110) during the 25th Annual Clinical...

Disparities 2010: Interview with Rep. Elijah Cummings (D-Md.)

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Rep. Cummings discuss cancer health disparities with the American Association for Cancer Research.

Disparities 2010: Interview with Deborah M. Smith, M.D., M.P.H.

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Dr. Smith as she speaks with the American Association for Cancer Research on the issue of cancer health disparities.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading